|
시장보고서
상품코드
2070378
일회용 내시경 시장 : 규모, 점유율, 성장, 산업 분석, 지역 인사이트 및 예측(2026-2034년)Disposable Endoscopes Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
일회용 내시경 시장의 성장 요인
세계 일회용 내시경 시장은 2025년에 31억 달러로 평가되었고, 2026년 35억 3,000만 달러에서 2034년까지 103억 달러로 성장할 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR)은 14.3%에 달할 전망입니다. 일회용 내시경은 소화기내과, 호흡기내과, 비뇨기과, 이비인후과, 정형외과 및 기타 임상 분야에서 진단 및 치료 시술에 사용되는 일회용 저침습 의료기기입니다.
이 시장은 병원 내 감염에 대한 우려가 커지고, 엄격한 감염 관리 지침이 시행되며, 멸균 처리된 일회용 기기에 대한 선호도가 높아짐에 따라 성장하고 있습니다. 이러한 내시경은 재처리 필요성을 없애고 교차 오염 위험을 줄여줍니다. 2025년에는 북미가 38.38%의 시장 점유율을 차지하며 세계 시장을 주도했습니다.
시장 동향
주요 시장 동향으로는 일회용 내시경 분야의 급속한 기술 발전이 꼽힙니다. 각 업체는 화질, 장비의 조작성, 작업 채널, 디지털 연결성 및 센서 통합을 개선하고 있습니다. 이러한 개선을 통해 재사용 가능한 내시경과 일회용 내시경 간의 성능 격차는 점차 좁혀지고 있습니다.
2024년 5월, Ambu사의 ‘aScope Gastro Large’는 작업 채널이 개선되어 치료 시술 시 임상 성능 향상에 기여한다는 점을 인정받아 FDA 승인을 획득했습니다.
시장 성장 촉진요인
감염 관리에 대한 우려가 커지면서, 이것이 시장 성장의 주요 촉진요인이 되고 있습니다. 재사용 가능한 내시경은 복잡한 세척 및 재처리 과정이 필요하지만, 그럼에도 불구하고 오염 위험이 남아 있을 수 있습니다. 한편, 일회용 내시경은 검사마다 멸균 처리된 기기를 제공함으로써 환자의 안전성을 높이고 감염 위험을 줄여줍니다. 규제 당국의 지원과 병원의 안전 프로토콜 또한 그 도입을 더욱 뒷받침하고 있습니다.
시장 성장 억제요인
높은 처리 비용이 주요 제약 요인으로 작용하고 있습니다. 일회용 내시경은 시술할 때마다 지속적으로 구입해야 하기 때문에 병원이나 진료소의 운영비가 증가합니다. 반면, 재사용 가능한 내시경은 초기 비용이 비싸지만 반복해서 사용할 수 있습니다. 특히 신흥국에서는 예산 제약이나 보험 환급과 관련된 문제가 도입을 제한할 가능성이 있습니다.
시장 기회
신흥 시장에서 의료 투자가 증가함에 따라 큰 기회가 열리고 있습니다. 아시아태평양 및 라틴아메리카에서는 의료 인프라의 개선, 감염 관리에 대한 인식 제고, 최소 침습 수술에 대한 수요 증가가 나타나고 있습니다. 또한, 소화기 및 호흡기 질환의 환자 수가 증가하고 있는 점도 일회용 내시경 수요를 뒷받침하고 있습니다.
2021년 1월, 인도의 AIG 병원이 일회용 십이지장 내시경 사용을 시작했으며, 이는 아시아 지역에서의 도입을 향한 중요한 한 걸음이 되었습니다.
시장의 과제
신흥국에서 숙련된 전문가의 부족은 여전히 과제로 남아 있습니다. 일회용 기기는 감염 위험을 줄여주지만, 검사를 실시하기 위해서는 여전히 훈련을 받은 내시경 전문의와 지원 인력이 필요합니다. 연수 프로그램의 부족이나 기술적 전문 지식의 결여는 검사의 효율성에 영향을 미치며, 첨단 내시경 기술의 보급을 지연시킬 가능성이 있습니다.
지역별 분석
북미는 2025년에 11억 9,000만 달러를 기록하며 세계 시장을 주도했고, 이는 2024년의 10억 4,000만 달러에서 증가한 수치입니다. 미국 시장은 2026년에 11억 8,000만 달러에 달할 것으로 예상되며, 이는 전 세계 매출의 약 33.4%를 차지할 것으로 전망됩니다.
아시아태평양은 2026년에 6억 6,000만 달러에 달하고, 지역별 시장 중에서는 2위 규모를 차지할 것으로 전망됩니다. 2026년 시장 규모는 중국이 2억 8,000만 달러, 일본이 1억 4,000만 달러, 인도가 1억 1,000만 달러에 달할 것으로 전망됩니다.
유럽 시장은 2026년에 10억 4,000만 달러에 달할 것으로 예측되며, 예측 기간 동안 연평균 13.3%의 성장률을 보일 것으로 전망됩니다. 2026년에는 영국 시장이 1억 9,000만 달러, 독일 시장이 2억 5,000만 달러에 달할 것으로 전망됩니다.
라틴아메리카는 의료 인프라 개선과 첨단 의료 기술의 보급 확대에 힘입어, 2026년에는 2억 3,000만 달러에 달할 것으로 추정됩니다. GCC 시장은 2026년에 7,000만 달러에 달할 것으로 전망됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 일회용 내시경 시장 분석, 인사이트 및 예측(2021-2034년)
제6장 북미 일회용 내시경 시장 분석, 인사이트 및 예측(2021-2034년)
제7장 유럽 일회용 내시경 시장 분석, 인사이트 및 예측(2021-2034년)
제8장 아시아태평양 일회용 내시경 시장 분석, 인사이트 및 예측(2021-2034년)
제9장 라틴아메리카 일회용 내시경 시장 분석, 인사이트 및 예측(2021-2034년)
제10장 중동 및 아프리카 일회용 내시경 시장 분석, 인사이트 및 예측(2021-2034년)
제11장 경쟁 분석
JHS 26.07.01Growth Factors of disposable endoscopes Market
The global disposable endoscopes market was valued at USD 3.10 billion in 2025 and is projected to grow from USD 3.53 billion in 2026 to USD 10.30 billion by 2034, registering a CAGR of 14.3% during the forecast period. Disposable endoscopes are single-use, minimally invasive medical devices used for diagnostic and therapeutic procedures in gastroenterology, pulmonology, urology, ENT, orthopedics, and other clinical areas.
The market is growing due to rising concerns over Hospital-Acquired Infections, strict infection-control guidelines, and increasing preference for sterile single-use devices. These endoscopes eliminate the need for reprocessing and reduce cross-contamination risks. North America dominated the global market in 2025 with a 38.38% market share.
Market Trends
A major market trend is the rapid technological advancement in disposable endoscopes. Companies are improving image quality, device maneuverability, working channels, digital connectivity, and sensor integration. These improvements are narrowing the performance gap between reusable and disposable scopes.
In May 2024, Ambu's aScope Gastro Large received FDA clearance with an improved working channel, supporting better clinical performance in therapeutic procedures.
Market Drivers
Rising infection-control concerns are a key driver of market growth. Reusable endoscopes require complex cleaning and reprocessing, yet contamination risks may still remain. Disposable endoscopes provide a sterile device for every procedure, improving patient safety and reducing infection risks. Regulatory support and hospital safety protocols are further encouraging adoption.
Market Restraints
High procedural cost is a major restraint. Disposable endoscopes require continuous procurement for every procedure, increasing operating expenses for hospitals and clinics. In comparison, reusable endoscopes involve high upfront cost but can be used repeatedly. Budget constraints and reimbursement challenges, especially in emerging countries, may restrict adoption.
Market Opportunities
Rising healthcare investments in emerging markets offer strong opportunities. Asia Pacific and Latin America are witnessing improvements in healthcare infrastructure, growing awareness of infection control, and rising demand for minimally invasive procedures. Increasing cases of gastrointestinal and respiratory disorders are also supporting demand for single-use endoscopes.
In January 2021, AIG Hospitals in India began using disposable duodenoscopes, marking an important step for adoption in Asia.
Market Challenges
Shortage of skilled professionals in emerging countries remains a challenge. Although disposable devices reduce infection risk, procedures still require trained endoscopists and support staff. Limited training programs and lack of technical expertise can affect procedural efficiency and slow adoption of advanced endoscopic technologies.
Segment Analysis
By product, the market is segmented into bronchoscopes, gastrointestinal endoscopes, ureteroscopes, and others. The gastrointestinal endoscope segment held the largest market share in 2025 due to the high volume of colonoscopy and gastroscopy procedures worldwide. The bronchoscope segment is projected to grow at a CAGR of 13.8% during the forecast period.
By application, the market is classified into gastroenterology, pulmonology, urology, orthopedics, and others. The gastroenterology segment dominated in 2025 due to the rising burden of digestive diseases and frequent use of endoscopy for diagnosis and treatment. The segment is expected to hold 35.1% share in 2026. The pulmonology segment is projected to grow at a CAGR of 13.5%.
By end user, the market includes hospitals & ASCs, specialty clinics, and others. Hospitals & ASCs dominated in 2025 due to high procedural volumes, strong infection-control focus, and preference for patient safety. This segment is expected to hold 70.5% share in 2026. Specialty clinics are projected to grow at a CAGR of 15.4%.
Regional Analysis
North America led the global market with USD 1.19 billion in 2025, increasing from USD 1.04 billion in 2024. The U.S. market is expected to reach USD 1.18 billion in 2026, accounting for approximately 33.4% of global revenue.
Asia Pacific is projected to reach USD 0.66 billion in 2026, becoming the second-largest regional market. China is expected to reach USD 0.28 billion, Japan USD 0.14 billion, and India USD 0.11 billion in 2026.
Europe is projected to reach USD 1.04 billion in 2026, growing at a 13.3% rate during the forecast period. The U.K. market is expected to reach USD 0.19 billion, while Germany is projected at USD 0.25 billion in 2026.
Latin America is estimated to reach USD 0.23 billion in 2026, supported by healthcare infrastructure improvements and rising adoption of advanced medical technologies. The GCC market is projected to reach USD 0.07 billion in 2026.
Competitive Landscape
The market is competitive, with leading companies focusing on product expansion, FDA clearances, innovation, digital imaging, and strategic partnerships. Key players include Boston Scientific Corporation, PENTAX Medical, Ambu A/S, Integrated Endoscopy, UroViu Corporation, CooperSurgical, Flexicare, Welch Allyn/Baxter, Olympus Corporation, and OTU Medical. Boston Scientific, Olympus, and Ambu held the highest market share in 2025 due to their broad single-use endoscope portfolios.
Key Industry Developments
In May 2025, Olympus received FDA 510(k) clearance for its EZ1500 series endoscopes. In July 2024, Ambu received FDA clearance for aScope 5 Uretero. In April 2024, Olympus launched Vathin E-SteriScope in the U.S. for ENT procedures. In April 2024, Ambu received FDA clearance for aScope Gastro Large. In September 2021, Boston Scientific launched EXALT Model D Duodenoscope and EXALT Model B Bronchoscope.
Conclusion
The disposable endoscopes market is expected to grow from USD 3.10 billion in 2025 to USD 3.53 billion in 2026, reaching USD 10.30 billion by 2034. Growth will be driven by infection-control concerns, minimally invasive procedure demand, regulatory support, and technology improvements. However, high per-procedure costs and skilled workforce shortages may challenge wider adoption.
Segmentation By Product, Application, End-user, and Region
By Product * Bronchoscope
- Gastrointestinal Endoscope
- Ureteroscope
- Others
By Application * Gastroenterology
- Pulmonology
- Urology
- Orthopedics
- Others
By End-user * Hospitals & ASCs
- Specialty Clinics
- Others
By Region * North America (By Product, Application, End-user, and Country)
- U.S. (By Product)
- Canada (By Product)
- Europe (By Product, Application, End-user, and Country/Sub-region)
- Germany (By Product)
- U.K. (By Product)
- France (By Product)
- Spain (By Product)
- Italy (By Product)
- Scandinavia (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, Application, End-user, and Country/Sub-region)
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Size, Procedure, End-user and Country/Sub-region)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, Application, End-user, and Country/Sub-region)
- GCC (By Product)
- South Africa (By Product)
- Rest of Middle East & Africa (By Product)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Conditions, by key Country/Region, 2025
- 4.2. Number of Key Procedures, by key Country/Region, 2025
- 4.3. Advancements in Disposable Endoscopes
- 4.4. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
5. Global Disposable Endoscopes Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Bronchoscope
- 5.1.2. Gastrointestinal Endoscope
- 5.1.3. Ureteroscope
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Gastroenterology
- 5.2.2. Pulmonology
- 5.2.3. Urology
- 5.2.4. Orthopedics
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Disposable Endoscopes Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Bronchoscope
- 6.1.2. Gastrointestinal Endoscope
- 6.1.3. Ureteroscope
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Gastroenterology
- 6.2.2. Pulmonology
- 6.2.3. Urology
- 6.2.4. Orthopedics
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Product
- 6.4.2. Canada
- 6.4.2.1. By Product
- 6.4.1. U.S.
7. Europe Disposable Endoscopes Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Bronchoscope
- 7.1.2. Gastrointestinal Endoscope
- 7.1.3. Ureteroscope
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Gastroenterology
- 7.2.2. Pulmonology
- 7.2.3. Urology
- 7.2.4. Orthopedics
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. Germany
- 7.4.1.1. By Product
- 7.4.2. U.K.
- 7.4.2.1. By Product
- 7.4.3. France
- 7.4.3.1. By Product
- 7.4.4. Italy
- 7.4.4.1. By Product
- 7.4.5. Spain
- 7.4.5.1. By Product
- 7.4.6. Scandinavia
- 7.4.6.1. By Product
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product
- 7.4.1. Germany
8. Asia Pacific Disposable Endoscopes Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Bronchoscope
- 8.1.2. Gastrointestinal Endoscope
- 8.1.3. Ureteroscope
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Gastroenterology
- 8.2.2. Pulmonology
- 8.2.3. Urology
- 8.2.4. Orthopedics
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. China
- 8.4.1.1. By Product
- 8.4.2. India
- 8.4.2.1. By Product
- 8.4.3. Japan
- 8.4.3.1. By Product
- 8.4.4. Australia
- 8.4.4.1. By Product
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product
- 8.4.1. China
9. Latin America Disposable Endoscopes Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Bronchoscope
- 9.1.2. Gastrointestinal Endoscope
- 9.1.3. Ureteroscope
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Gastroenterology
- 9.2.2. Pulmonology
- 9.2.3. Urology
- 9.2.4. Orthopedics
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product
- 9.4.2. Mexico
- 9.4.2.1. By Product
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product
- 9.4.1. Brazil
10. Middle East & Africa Disposable Endoscopes Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Bronchoscope
- 10.1.2. Gastrointestinal Endoscope
- 10.1.3. Ureteroscope
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Gastroenterology
- 10.2.2. Pulmonology
- 10.2.3. Urology
- 10.2.4. Orthopedics
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals & ASCs
- 10.3.2. Specialty Clinics
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Product
- 10.4.2. GCC
- 10.4.2.1. By Product
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Product
- 10.4.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Boston Scientific Corporation
- 11.2.2. PENTAX Medical
- 11.2.3. Ambu A/S
- 11.2.4. Integrated Endoscopy
- 11.2.5. UroViu Corporation
- 11.2.6. CooperSurgical Inc.
- 11.2.7. Flexicare (Group) Limited
- 11.2.8. WELCH ALLYN (Baxter)
- 11.2.9. Olympus Corporation
- 11.2.10. OTU Medical
